This extension brought the company's total funding to date to $30 million. The round was co-led by Sofinnova Partners and Bertelsmann Investments, with new investments from KHP Ventures and SwissHealth Ventures, as well as continued support from existing investor Winning Mindset Ventures.

The new funds will be allocated to accelerate deepc’s growth and international expansion, as well as to further enhance and commercialise its advanced operating system. The company’s strategic growth priorities include expanding its footprint in the United States, increasing its presence in the United Kingdom, and reinforcing its market position in key European regions.

Currently, deepc’s platform is utilised by notable institutions such as Solothurn Hospital in Switzerland, the Vivantes Hospital Group and LMU University Hospital in Germany, CHU Brugmann (Brugmann University Hospital) in Belgium, and the National Health Service (NHS) in England.

Dr Franz Pfister, CEO and Co-Founder of deepc, said: "At deepc, we believe that the potential for AI in healthcare will only be realised if we can bridge the gap between cutting-edge AI and clinical practice. Our platform makes it easy for organizations to adopt the best AI technologies at pace and at scale, enabling faster, more accurate diagnoses and ultimately improving patient outcomes. We are thrilled to welcome SwissHealth Ventures and KHP Ventures, alongside our existing investors Sofinnova Partners, Bertelsmann Investments, and Winning Mindset Ventures. Together, they bring tremendous strategic value to deepc and will be a major asset as we continue to scale internationally and invest further in our platform."

Simon Turner, Partner at Sofinnova Partners, said: "The influx of capital into AI is highlighting the importance of enabling technologies that drive adoption in healthcare. These enabling technologies are the focus of the Sofinnova Digital Medicine strategy, and an area that few have yet to command. From the outset, we recognized deepc's potential to revolutionize AI deployment in healthcare. This conviction is reinforced today by the support of our new investors who bring a wealth of expertise to further accelerate the company's growth.”

Daniel Dickens, Managing Partner at KHP Ventures, said: “deepc is solving a fundamental challenge for health systems, who understand the value that AI can deliver but often struggle to navigate the technical and commercial complexities of deploying it at scale. deepc has proven it can partner with health systems to solve these problems for the benefit of patients and clinical teams, and we look forward to supporting their growth within the NHS and beyond.”

Founded in 2019, deepc is driven by a vision to help ensure precise and safe diagnostics for all patients and has a strong track record of helping radiology AI providers deploy their technologies in clinical settings through a single integration solution.

Through deepcOS, clinicians can access regulatory-approved AI solutions for more than 60 clinical indications, allowing healthcare providers to benefit from the rapid developments taking place within radiology AI without any of the technical, operational, or commercial complexity. By giving AI developers low-friction access to deepc’s broad customer base and distribution network spanning over 30 countries, deepc is also helping accelerate the development of new AI solutions.